Home > > > > > Report Detail

Fungal Foot Infections Drug Development Pipeline Review, 2018

Publisher Name :
Date: 22-Mar-2018
No. of pages: 58

Summary

This report provides an overview of the fungal foot infection pipeline landscape. It provides comprehensive information on the therapeutics under development for onychomycosis (Tinea unguium) and athlete's foot (Tinea pedis), and key players active within these indications.

Both of these indications are fungal infections primarily affecting the feet. Onychomycosis affects the nails, whereas athlete's foot affects the skin under the feet and between the toes. Common symptoms include discomfort, itchiness, and in the case of onychomycosis discoloured and disfigured nails. Combined, these infections affect around 25% of the adult population.

There is considerable overlap in both the development of pipeline products and existing marketed products between the two indications, which reflects similarities in the underlying pathophysiology. There are a total of 25 products in development for both indications, by 24 companies.

Scope


  • Which companies are the most active within each pipeline?

  • Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?

  • To what extent do universities and institutions play a role within this pipeline, compared with pharmaceutical companies?

  • What are the most important R&D milestones and data publications to have happened in this disease area?


Reasons to buy


  • Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication

  • Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication, and a comprehensive picture of recent updates and milestones for each

  • Analyze the companies currently operating in the pipeline, and the products being fielded by each of these

  • Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration

Fungal Foot Infections Drug Development Pipeline Review, 2018

Table of Contents

1 Table of Contents 4
1.1 List of Tables 5
1.2 List of Figures 6

2 Introduction 7
2.1 Fungal Foot Infections Report Coverage 7
2.2 Onychomycosis (Tinea Unguium) - Overview 7
2.3 Tinea pedis (Athlete Foot) - Overview 7

3 Therapeutics Development 8
3.1 Onychomycosis (Tinea Unguium) 8
3.2 Tinea pedis (Athlete Foot) 12

4 Therapeutics Assessment 15
4.1 Onychomycosis (Tinea Unguium) 15
4.2 Tinea pedis (Athlete Foot) 21

5 Companies Involved in Therapeutics Development 26
5.1 Onychomycosis (Tinea Unguium) 26
5.2 Tinea pedis (Athlete Foot) 32

6 Dormant Projects 36
6.1 Onychomycosis (Tinea Unguium) 36
6.2 Tinea pedis (Athlete Foot) 38

7 Discontinued Products 39
7.1 Onychomycosis (Tinea Unguium) 39

8 Product Development Milestones 40
8.1 Onychomycosis (Tinea Unguium) 40
8.2 Tinea pedis (Athlete Foot) 50

9 Appendix 57
9.1 Methodology 57
9.2 Coverage 57
9.3 Secondary Research 57
9.4 Primary Research 57
9.5 Expert Panel Validation 57
9.6 Contact Us 58
9.7 Disclaimer 58

List of Tables

Table 1: Number of Products under Development for Onychomycosis (Tinea Unguium) 8
Table 2: Number of Products under Development by Companies, Onychomycosis (Tinea Unguium) 10
Table 3: Products under Development by Companies, Onychomycosis (Tinea Unguium) 11
Table 4: Number of Products under Development for Tinea pedis (Athlete Foot) 12
Table 5: Number of Products under Development by Companies, Tinea pedis (Athlete Foot) 13
Table 6: Products under Development by Companies, Tinea pedis (Athlete Foot) 14
Table 7: Number of Products by Stage and Target, Onychomycosis (Tinea Unguium) 16
Table 8: Number of Products by Stage and Mechanism of Action, Onychomycosis (Tinea Unguium) 17
Table 9: Number of Products by Stage and Route of Administration, Onychomycosis (Tinea Unguium) 19
Table 10: Number of Products by Stage and Molecule Type, Onychomycosis (Tinea Unguium) 20
Table 11: Number of Products by Stage and Target, Tinea pedis (Athlete Foot) 22
Table 12: Number of Products by Stage and Mechanism of Action, Tinea pedis (Athlete Foot) 23
Table 13: Number of Products by Stage and Route of Administration, Tinea pedis (Athlete Foot) 25
Table 14: Number of Products by Stage and Molecule Type, Tinea pedis (Athlete Foot) 25
Table 15: Onychomycosis (Tinea Unguium) - Pipeline by Almirall SA 26
Table 16: Onychomycosis (Tinea Unguium) - Pipeline by Blueberry Therapeutics Ltd 27
Table 17: Onychomycosis (Tinea Unguium) - Pipeline by Dermala Inc 27
Table 18: Onychomycosis (Tinea Unguium) - Pipeline by Eisai Co Ltd 27
Table 19: Onychomycosis (Tinea Unguium) - Pipeline by Helix BioMedix Inc 28
Table 20: Onychomycosis (Tinea Unguium) - Pipeline by Hexima Ltd 28
Table 21: Onychomycosis (Tinea Unguium) - Pipeline by Kaken Pharmaceutical Co Ltd 29
Table 22: Onychomycosis (Tinea Unguium) - Pipeline by Meiji Seika Pharma Co Ltd 29
Table 23: Onychomycosis (Tinea Unguium) - Pipeline by Moberg Pharma AB 30
Table 24: Onychomycosis (Tinea Unguium) - Pipeline by NAL Pharmaceuticals Ltd 30
Table 25: Onychomycosis (Tinea Unguium) - Pipeline by Novabiotics Ltd 31
Table 26: Onychomycosis (Tinea Unguium) - Pipeline by Novan Inc 31
Table 27: Onychomycosis (Tinea Unguium) - Pipeline by Viamet Pharmaceuticals Inc 32
Table 28: Tinea pedis (Athlete Foot) - Pipeline by Astellas Pharma Inc 32
Table 29: Tinea pedis (Athlete Foot) - Pipeline by Biolab Farmaceutica Ltda 33
Table 30: Tinea pedis (Athlete Foot) - Pipeline by Blueberry Therapeutics Ltd 33
Table 31: Tinea pedis (Athlete Foot) - Pipeline by Broda Tech LLC 34
Table 32: Tinea pedis (Athlete Foot) - Pipeline by Novan Inc 34
Table 33: Tinea pedis (Athlete Foot) - Pipeline by Novoteris LLC 35
Table 34: Tinea pedis (Athlete Foot) - Pipeline by Sanotize Research And Development Corp 35
Table 35: Tinea pedis (Athlete Foot) - Pipeline by Viamet Pharmaceuticals Inc 35
Table 36: Onychomycosis (Tinea Unguium) - Dormant Projects 36
Table 37: Tinea pedis (Athlete Foot) - Dormant Projects 38
Table 38: Onychomycosis (Tinea Unguium) - Discontinued Products 39

List of Figures

Figure 1: Number of Products under Development for Onychomycosis (Tinea Unguium) 8
Figure 2: Number of Products under Development by Companies, Onychomycosis (Tinea Unguium) 9
Figure 3: Number of Products under Development for Tinea pedis (Athlete Foot) 12
Figure 4: Number of Products under Development by Companies, Tinea pedis (Athlete Foot) 13
Figure 5: Number of Products by Targets, Onychomycosis (Tinea Unguium) 15
Figure 6: Number of Products by Stage and Targets, Onychomycosis (Tinea Unguium) 15
Figure 7: Number of Products by Mechanism of Actions, Onychomycosis (Tinea Unguium) 16
Figure 8: Number of Products by Stage and Mechanism of Actions, Onychomycosis (Tinea Unguium) 17
Figure 9: Number of Products by Routes of Administration, Onychomycosis (Tinea Unguium) 18
Figure 10: Number of Products by Stage and Routes of Administration, Onychomycosis (Tinea Unguium) 18
Figure 11: Number of Products by Molecule Types, Onychomycosis (Tinea Unguium) 19
Figure 12: Number of Products by Stage and Molecule Types, Onychomycosis (Tinea Unguium) 20
Figure 13: Number of Products by Targets, Tinea pedis (Athlete Foot) 21
Figure 14: Number of Products by Stage and Targets, Tinea pedis (Athlete Foot) 21
Figure 15: Number of Products by Mechanism of Actions, Tinea pedis (Athlete Foot) 22
Figure 16: Number of Products by Stage and Mechanism of Actions, Tinea pedis (Athlete Foot) 23
Figure 17: Number of Products by Routes of Administration, Tinea pedis (Athlete Foot) 24
Figure 18: Number of Products by Stage and Routes of Administration, Tinea pedis (Athlete Foot) 24
Figure 19: Number of Products by Stage and Molecule Types, Tinea pedis (Athlete Foot) 25

  • Global Cephalosporin Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 109
    Cephalosporin is an antibiotic medication commonly prescribed to treat several different types of infections. Cephalosporin originally derived from The fungus Acremonium, which was previously known as "Cephalosporium". The global Cephalosporin market was valued at US$ 1380.7 million in 2023 and is anticipated to reach US$ 1346.9 million by 2030, witnessing a CAGR of -0.3% during The forecast period 2024-2030. Market competition is intense. Qilu Antibiotics, Nectar Lifes......
  • Global Polymixin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 120
    According to our LPI (LP Information) latest study, the global Polymixin market size was valued at US$ 229.9 million in 2023. With growing demand in downstream market, the Polymixin is forecast to a readjusted size of US$ 291 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Polymixin market. Polymixin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and sup......
  • Global Sepsis Partnering Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The Sepsis Partnering market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sepsis Partnering market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape......
  • Global Cephalosporin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 156
    According to our LPI (LP Information) latest study, the global Cephalosporin market size was valued at US$ 1350.7 million in 2023. With growing demand in downstream market, the Cephalosporin is forecast to a readjusted size of US$ 1319.6 million by 2030 with a CAGR of -0.3% during review period. The research report highlights the growth potential of the global Cephalosporin market. Cephalosporin are expected to show stable growth in the future market. However, product differentiation, re......
  • Global Amoxicillin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 127
    According to our LPI (LP Information) latest study, the global Amoxicillin market size was valued at US$ 4512.7 million in 2023. With growing demand in downstream market, the Amoxicillin is forecast to a readjusted size of US$ 5711.7 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Amoxicillin market. Amoxicillin are expected to show stable growth in the future market. However, product differentiation, reducing co......
  • Global Metronidazole Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 136
    According to our LPI (LP Information) latest study, the global Metronidazole market size was valued at US$ 110.5 million in 2023. With growing demand in downstream market, the Metronidazole is forecast to a readjusted size of US$ 106.6 million by 2030 with a CAGR of -0.5% during review period. The research report highlights the growth potential of the global Metronidazole market. Metronidazole are expected to show stable growth in the future market. However, product differentiation, redu......
  • Global Drugs for Herpes Labialis (Oral Herpes) Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131
    According to our LPI (LP Information) latest study, the global Drugs for Herpes Labialis (Oral Herpes) market size was valued at US$ 2404.5 million in 2023. With growing demand in downstream market, the Drugs for Herpes Labialis (Oral Herpes) is forecast to a readjusted size of US$ 3402.2 million by 2030 with a CAGR of 5.1% during review period. The research report highlights the growth potential of the global Drugs for Herpes Labialis (Oral Herpes) market. Drugs for Herpes Labialis (Ora......
  • Global Ampicillin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 93
    According to our LPI (LP Information) latest study, the global Ampicillin market size was valued at US$ 161.6 million in 2023. With growing demand in downstream market, the Ampicillin is forecast to a readjusted size of US$ 194.7 million by 2030 with a CAGR of 2.7% during review period. The research report highlights the growth potential of the global Ampicillin market. Ampicillin are expected to show stable growth in the future market. However, product differentiation, reducing costs, a......
  • Global Acinetobacter Infections Treatment Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 101
    According to our LPI (LP Information) latest study, the global Acinetobacter Infections Treatment market size was valued at US$ million in 2023. With growing demand in downstream market, the Acinetobacter Infections Treatment is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Acinetobacter Infections Treatment market. Acinetobacter Infections Treatment are expected to show stable ......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs